Properties
Description
ACTB-1003 is a protein tyrosine kinase inhibitor that has shown potent biochemical activity against FGFR. It targets FGFR1, Tie-2, and VEGFR2.
Molecular Formula
C27H26F5N7O3
Targets
FGFR1: 6 nM; Tie-2: 4 nM; VEGFR2: 2 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
ACTB-1003 is an FGFR inhibitor utilized for therapeutic research in malignancies involving dysregulated FGFR pathways.